[1]
R. RADKE and N. K. JAIN, “ENHANCEMENT OF SOLUBILITY AND BIOAVAILABILITY OF BCS CLASS-II AMBRISENTAN: IN VITRO, IN VIVO AND EX VIVO ANALYSIS”, Int J App Pharm, vol. 14, no. 1, pp. 67–74, Jan. 2022.